News Agency
The Times

BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures

  • Written by PR Newswire
BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- MSQ Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) and an associated investor for the development of motixafortide...

Read more: BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion